Mazdutide Price Comparison — Compare 3 Vendors
Price Comparison
Compare vendors · per 5mg
| Vendor | Price | $ / mg | Updated | |
|---|---|---|---|---|
| Pantheon Peptides6/10 | $97.20 | $9.72 | Apr 23, 2026 | Buy → |
| Hydro Research9/10 | $648.00 | $10.80 | Jun 5, 2026 | Buy → |
| Modern Aminos9/10 | $58.00 | $11.60 | May 14, 2026 | Buy → |
Research details
Mazdutide — research data
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Overview
About Mazdutide
Mechanism of action
Dual GLP-1 receptor and glucagon receptor (GCGR) agonist; GLP-1 component suppresses appetite and improves glycemia; glucagon component increases energy expenditure, promotes lipolysis, and reduces hepatic fat; weekly injection.
Safety profile
Nausea, vomiting, diarrhea, decreased appetite; glucagon effects may include hyperglycemia at high doses; still in trials. · Phase III trials ongoing; GI side effects; dual agonist; promising efficacy and tolerability
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Mazdutide below your target.
Related pages
More on Mazdutide
Research
Studies & key findings
- Mazdutide (IBI362 / LY3305677) is a dual GLP-1 + glucagon receptor agonist — an oxyntomodulin analog — distinct from tirzepatide (GIP/GLP-1). The glucagon arm adds thermogenesis/energy expenditure on top of GLP-1 appetite suppression.
- Reported Phase 3 results (GLORY program, Innovent/Lilly, largely Chinese cohorts) describe up to ~20% weight loss at 9 mg over 60 weeks — but these figures are company/topline-stage and should be confirmed against the primary publications before being treated as established.